A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2006
11/02/2006	WO2006115436A1 Medicinal agent for preventing progression of apoptotic and jugulating necrotic changes in the organism tissues
11/02/2006	WO2006115414A1 Device for preparing a drink
11/02/2006	WO2006115198A1 Porous cellulose aggregate and molding composition thereof
11/02/2006	WO2006115155A1 Liposome-containing preparation and process for producing the same
11/02/2006	WO2006114868A1 Medicinal preparation for percutaneous absorption
11/02/2006	WO2006114709A1 Pharmaceutical compositions of antiretrovirals
11/02/2006	WO2006114604A2 Water-soluble films comprising nicotine
11/02/2006	WO2006114484A1 Method for producing and preserving physiological media and products obtainable by said method
11/02/2006	WO2006114448A2 A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit
11/02/2006	WO2006114277A2 Dosage form with improved release of cefuroximaxetil
11/02/2006	WO2006114054A1 Use of amorphophallus rivieri durieu and extract thereof in the manufacture of a medicament for treating acute, chronic bronchitis
11/02/2006	WO2006114042A1 Application of levo-ornidazole in preparation of anti-anaerobic bacteria infection medicine
11/02/2006	WO2006091576A3 Spreadable warming lubricant
11/02/2006	WO2006087629A3 Rapidly disintegrating composition of olanzapine
11/02/2006	WO2006087233A3 Release of extracellular membrane particles carrying the stem cell marker prominin-1 (cd133) from neural progenitors and other epithelial cells
11/02/2006	WO2006084474A3 A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an hmg-coa reductase inhibitor
11/02/2006	WO2006076338A3 Dosage form for treating gastrointestinal disorders
11/02/2006	WO2006072948A3 Gastro-retentive diagnostic assemblies
11/02/2006	WO2006072613A3 Preparation comprising microparticles of an insoluble polysaccharide resin with a biopolymeric active ingredient and method for production thereof
11/02/2006	WO2006071584A8 Release particle composition, process for making same, and composition having such particles
11/02/2006	WO2006062826A3 Anti-viral uses of metal nanomaterial compositions
11/02/2006	WO2006059344B1 Compositions for combating beta-lactamase-mediated antibiotic resistance using beta-lactamase inhibitors useful for injection
11/02/2006	WO2006020618A8 Compositions and methods for treating leukemia
11/02/2006	WO2006007461A3 Optically controlled microfluidic chip
11/02/2006	WO2005092272A8 Film products having controlled disintegration properties
11/02/2006	WO2005092271A8 Film compositions
11/02/2006	WO2005086641A3 Anti-infectious hydrogel compositions
11/02/2006	WO2005084637A3 Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof
11/02/2006	WO2005072125A3 Composite materials for controlled release of water soluble products
11/02/2006	WO2005070080A3 Methods of using zonisamide as an adjunctive therapy for partial seizures
11/02/2006	WO2005067517A3 Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers
11/02/2006	US20060247605 Implantable dialysis access port
11/02/2006	US20060247456 Reaction product of fatty acid in basic aqueous solution with alkali earth metal sulfate (magnesium sulfate, calcium sulfate)
11/02/2006	US20060247451 Crystalline base of citalopram
11/02/2006	US20060247426 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment
11/02/2006	US20060247308 Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
11/02/2006	US20060247306 Radiation protection by gamma-tocotrienol
11/02/2006	US20060247234 Compositions containing micronized tanaproget prepared by wet granulation
11/02/2006	US20060247203 Freeze-dried preparation containing methylcobalamin and process for producing the same
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	US20060247183 Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
11/02/2006	US20060246499 sugar polyacrylate gels, used for conjugation and analysis of nucleotides, peptides, proteins, antigens, antibodies or polysaccharides; bioassays
11/02/2006	US20060246145 Methods for treating ocular conditions with cyclic lipid containing microparticles
11/02/2006	US20060246144 Microcapsules containing biocide and preparation thereof by solvent evaporation technique
11/02/2006	US20060246143 Targeted therapy via targeted delivery of energy susceptible nanoscale magnetic particles
11/02/2006	US20060246142 Nanoparticulate quinazoline derivative formulations
11/02/2006	US20060246141 Nanoparticulate lipase inhibitor formulations
11/02/2006	US20060246140 Method for the preparation of molecular complexes
11/02/2006	US20060246139 lactic acid-glycolic acid copolymer with an adjusted distribution in molecular weight can be used as a biodegradable release-sustaining base material; drug is a luteinizing hormone-releasing hormone, agonist or antagonist
11/02/2006	US20060246138 Polyoxaester suspending vehicles for use with implantable delivery systems
11/02/2006	US20060246137 Complex matrix for biomedical use
11/02/2006	US20060246136 Systems, methods and apparatuses for manufacturing dosage forms
11/02/2006	US20060246135 Micronized tanaproget, compositions, and methods of preparing the same
11/02/2006	US20060246134 Timed, pulsatile release systems
11/02/2006	US20060246133 Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same
11/02/2006	US20060246132 Sustained release formulations of venlafaxine
11/02/2006	US20060246131 Use of metformin to counteract weight gain associated with psychotropic medications
11/02/2006	US20060246130 Compositions and methods for combination antiviral therapy
11/02/2006	US20060246128 Micronized tanaproget and compositions containing same
11/02/2006	US20060246127 Moulded body made from a gelatine-free material filled with a liquid filling
11/02/2006	US20060246126 Therapeutic liposome composition and method of preparation
11/02/2006	US20060246125 Proteoliposome for use as gene transfer tool in treatment and diagnosis of cardiomyopathy, type II diabetes, Alzheimer's, Parkinson's diseases; gene therapy
11/02/2006	US20060246124 Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
11/02/2006	US20060246123 Oligonucleotide mimetics
11/02/2006	US20060246122 Solid transdermal therapeutic system with UV absorber
11/02/2006	US20060246121 Particle-containing complex porous materials
11/02/2006	US20060246120 Antiseptic wipes
11/02/2006	US20060246119 Cosmetic device comprising nonwoven web
11/02/2006	US20060246118 Process of heating a carrier on which or inside which a cosmetic product is placed
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	US20060246103 Implantable devices for the delivery of therapeutic agents to an orthopaedic surgical site
11/02/2006	US20060246101 Oral controlled release formulations
11/02/2006	US20060246096 Nanoparticles from biopolymers
11/02/2006	US20060246094 Inactivated vibrio cholerae vaccine in tablet form
11/02/2006	US20060246088 Use of HIV-1 gp120 and gp160 proteins modified in the V3 loop for the preparation of vaccine compositions and formulations containing the same
11/02/2006	US20060246087 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration
11/02/2006	US20060246085 Methods for manipulating satiety
11/02/2006	US20060246060 Novel stable formulation
11/02/2006	US20060246053 Frozen and lyophilized compositions for a metalloproteinase fibrinolytic agent (fibrolase or "novel acting thrombolytic agent" (NAT) with buffer of sodium citrate, zinc acetate, and/or calcium acetate; regeneration
11/02/2006	US20060246043 Cellular preparation
11/02/2006	US20060246039 Growth differentiation factor-7
11/02/2006	US20060246033 Injectable bulking agent compositions
11/02/2006	US20060246028 Di-glycosil glyceryl compounds for the stabilisation and preservation of biomaterials
11/02/2006	US20060246015 Compositions and methods for the maintenance of oral health
11/02/2006	US20060246013 Pump system for dispensing foaming eyelid cleanser
11/02/2006	US20060246012 Delivery of physiologically active compounds through an inhalation route
11/02/2006	US20060246011 Delivery of diphenhydramine through an inhalation route
11/02/2006	US20060246010 Process for Determining the particle size distribution of an aerosol and apparatus for carrying out such a process
11/02/2006	US20060246009 Novel Crystalline Forms of Tiotropium Bromide
11/02/2006	US20060246007 Use of osmolytes obtained from extremophilic bacteria the production of inhalable medicaments for the prophylaxis and treatment of pulmonary and cardiovascular diseases and an inhalation device comprising an osmolyte as active agent component
11/02/2006	US20060245998 Method for the preparation of a composition of nanoparticles of at least one crystalline metal oxide
11/02/2006	US20060243276 Methods for treating rhinitis and conjunctivitis
11/02/2006	EP1716868A1 Anti-inflammatory analgesic for external use
11/02/2006	EP1716866A1 Proteoliposomes and derivatives thereof as cytotoxic response-inducing adjuvants and resulting formulations
11/02/2006	EP1716855A1 Remedy for external use for skin and mucosal injuries caused by viral infection
11/02/2006	EP1716850A1 Transdermal plaster
11/02/2006	EP1716849A1 Coating of small particles
11/02/2006	EP1716848A1 Solid pharmaceutical composition containing a crystalline derivative of piperidine substituted in the 1,4 position
11/02/2006	EP1716847A1 Bioabsorbable pharmaceutical formulation comprising a PLGA copolymer
11/02/2006	EP1716846A2 Preparation and use of hydrogels

1 ... 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 ... 2991